Human kallikrein hK2 has low kininogenase activity while prostate- specific antigen (hK3) has none

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1343, Issue 1, 1997, Pages 102-106

  Deperthes, David ^a   Marceau, François ^c   Frenette, Gilles ^c   Lazure, Claude ^b   Tremblay, Roland R ^a   Dubé, Jean Y ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c NONE

Author keywords

Bradykinin; Kallikrein; Kininogen; Seminal plasma

Indexed keywords

BRADYKININ; KALLIKREIN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; ENZYME ACTIVITY; HUMAN; HYDROLYSIS; JUGULAR VEIN; KALLIKREIN KININ SYSTEM; MOLECULAR WEIGHT; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RABBIT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEMINAL PLASMA;

ANIMALS; ENZYME ACTIVATION; HUMANS; KALLIKREINS; MALE; PROSTATE-SPECIFIC ANTIGEN; RABBITS;

EID: 0031456637     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(97)00135-0     Document Type: Article

References (15)

1. Bhoola K.D., Figueroa C.D., Worthy K. Pharmacol. Rev. 44:1992;1-80.
2. T. Berg, R.A. Bradshaw, O.A. Carretero, J. Chao, L. Chao, J.A. Clements, M. Fahnestock, H. Fritz, F. Gauthier, R.R. MacDonald, H.S. Margolius, B.J. Morris, R.I. Richards, A.G. Scicli, in: H. Fritz, W. Muller-Esterl, M. Jochum, A. Roscher, K. Lubppertz (Eds.), Recent Progress on Kinins: Biochemistry and Molecular Biology of the Kallikrein-Kinin System, vol. I, Birkhauser, Basel, 1992, pp. 19-25.
3. MacDonald R.J., Southard-Smith M., Kroon E. J. Biol. Chem. 271:1996;13684-13690.
4. Deperthes D., Chapdelaine P., Tremblay R.R., Brunet C., Berton J., Hébert J., Lazure C., Dubé J.Y. Biochim. Biophys. Acta. 1245:1995;311-316.
5. Frenette G., Deperthes D., Tremblay R.R., Lazure C., Dubé J.Y. Biochim. Biophys. Acta. 1334:1997;109-115.
6. Deperthes D., Frenette G., Brillard-Bourdet M., Bourgeois L., Gauthier F., Tremblay R.R., Dubé J.Y. J. Androl. 17:1996;659-665.
7. Kumar A., Goel A.S., Hill T.M., Mikolajczyk S.D., Millar L.S., Kuus-Reichel K., Saedi M.S. Cancer Res. 56:1996;5397-5402.
8. Schill W.B., Miska W. Andrologia. 24:1992;69-75.
9. Fink E., Schill W.B., Fiedler F., Krassnigg F., Geiger R., Shimamoto K. Biol. Chem. Hoppe Seyler. 366:1985;917-924.
10. Espana F., Fink E., Sanchez-Cuenca J., Gilabert J., Estelles A., Witzgall K. Eur. J. Biochem. 234:1995;641-649.
11. Fichtner J., Graves H.C.B., Thatcher K., Yemoto C., Shortliffe L.M.D. J. Urol. 155:1996;738-742.
12. Marceau F., Levesque L., Drapeau G., Rioux F., Salvino J.M., Wolfe H.R., Seoane P.R., Sawitz D.G. J. Pharmacol. Exp. Ther. 269:1994;1136-1143.
13. Laemmli U.K. Nature (London). 227:1970;680-685.
14. Wang M.C., Valenzuela L.A., Murphy G.P., Chu T.M. Oncology. 39:1982;1-5.
15. Sakamoto W., Satoh F., Gotoh K., Uehara S. FEBS Lett. 219:1987;437-440.